Seyitler Kimya Sanayi AS (SEYKM) - Total Liabilities
Based on the latest financial reports, Seyitler Kimya Sanayi AS (SEYKM) has total liabilities worth TL60.64 Million TRY (≈ $1.36 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Seyitler Kimya Sanayi AS - Total Liabilities Trend (2012–2024)
This chart illustrates how Seyitler Kimya Sanayi AS's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Seyitler Kimya Sanayi AS's working capital to evaluate short-term liquidity relative to the company's equity base.
Seyitler Kimya Sanayi AS Competitors by Total Liabilities
The table below lists competitors of Seyitler Kimya Sanayi AS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Premier Foods PLC
LSE:PFD
|
UK | GBX814.70 Million |
|
Milestone Scientific
NYSE MKT:MLSS
|
USA | $5.94 Million |
|
Hansol Homedec
KO:025750
|
Korea | ₩128.30 Billion |
|
Groupe Tera SA
PA:ALGTR
|
France | €12.87 Million |
|
Biofish Holding AS
OL:BFISH
|
Norway | Nkr84.95 Million |
|
Promimic AB
ST:PRO
|
Sweden | Skr16.60 Million |
|
Grafton Group plc
LSE:GFTU
|
UK | GBX1.26 Billion |
|
Wealth Minerals Ltd.
V:WML
|
Canada | CA$1.83 Million |
Liability Composition Analysis (2012–2024)
This chart breaks down Seyitler Kimya Sanayi AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SEYKM market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Seyitler Kimya Sanayi AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Seyitler Kimya Sanayi AS (2012–2024)
The table below shows the annual total liabilities of Seyitler Kimya Sanayi AS from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | TL27.55 Million ≈ $617.04K |
-62.63% |
| 2023-12-31 | TL73.71 Million ≈ $1.65 Million |
+33.04% |
| 2022-12-31 | TL55.41 Million ≈ $1.24 Million |
+146.63% |
| 2021-12-31 | TL22.47 Million ≈ $503.17K |
-6.67% |
| 2020-12-31 | TL24.07 Million ≈ $539.13K |
+155.40% |
| 2019-12-31 | TL9.42 Million ≈ $211.09K |
+176.94% |
| 2018-12-31 | TL3.40 Million ≈ $76.22K |
+36.83% |
| 2017-12-31 | TL2.49 Million ≈ $55.70K |
-61.63% |
| 2016-12-31 | TL6.48 Million ≈ $145.19K |
+132.64% |
| 2015-12-31 | TL2.79 Million ≈ $62.41K |
+47.12% |
| 2014-12-31 | TL1.89 Million ≈ $42.42K |
-7.47% |
| 2013-12-31 | TL2.05 Million ≈ $45.85K |
-28.90% |
| 2012-12-31 | TL2.88 Million ≈ $64.48K |
-- |
About Seyitler Kimya Sanayi AS
Seyitler Kimya Sanayi A.S. develops and sells medical adhesive tape products in Turkey. The company offers health medical plasters, first aid patches, wound dressings, dialysis kits, eye pads, capsicum, and rheumatism plasters used in health institutions. It also provides surgical tapes, first aid strips, band-aid, biocidal products, disposable surgical products, injection series, and wound care … Read more